ENTITY
Kalbe Farma

Kalbe Farma (KLBF IJ)

147
Analysis
Health CareIndonesia
PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.
more
Refresh
28 Feb 2022 16:24

The Week That Was in ASEAN@Smartkarma - XL Coverging, Kalbe Rebalancing, and SCB Refocusing

The Week That Was in ASEAN@Smartkarma is filled with an eclectic mix of differentiated, substantive, and actionable insights, macro and equity...

Logo
180 Views
Share
bullishKalbe Farma
24 Feb 2022 20:39

Kalbe Farma (KLBF IJ) - Rebalancing Growth

Kalbe Farma released reassuring results for 2021 with growth coming from prescription drugs and distribution but 2022 will see a recovery across...

Logo
237 Views
Share
18 Jan 2022 16:40

PT Surya Citra Media Tbk (SCMA IJ) - Undervalued in Digital

PT Surya Citra Media Tbk (SCMA IJ) looks like the undervalued child of Emtek (EMTK IJ), despite its move into the OTT and digital advertising space...

Logo
277 Views
Share
06 Dec 2021 15:36

The Week That Was in ASEAN@Smartkarma - Grab Listing, Cimory IPO, and Kalbe Farma

The week that was in ASEAN@Smartkarma is filled with an eclectic mix of differentiated, substantive, and actionable insights, macro and equity...

Logo
209 Views
Share
06 Dec 2021 02:57

Cisarua Mountain Dairy (Cimory) IPO: Trading Debut

Cimory priced its IPO at IDR3,080.00 per share. Our DCF value of IDR3,331.04 per share is an 8% upside to the IPO price. The IPO price is fair but...

Logo
334 Views
Share
x